Ensemble forecasting of a continuously decreasing trend in bladder cancer incidence in Taiwan

Bo-Yu Hsiao1, Shih-Yung Su1,2, Jing-Rong Jhuang1,3

  • 1Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Rm. 536, No. 17, Xuzhou Rd., Taipei 100, Taiwan.

Scientific Reports
|April 17, 2021
PubMed

Insights

Bladder cancer incidence in Taiwan is decreasing for both men and women. Projections indicate a significant reduction, exceeding the World Health Organization

Area of Science:

  • Oncology
  • Epidemiology
  • Public Health

Background:

  • Bladder cancer is a significant global health concern, representing a substantial portion of urinary system malignancies.
  • The World Health Organization's '25 by 25' goal necessitates effective strategies for reducing non-communicable disease burdens, including cancer.
  • Understanding incidence trends is crucial for public health planning and intervention development.

Purpose of the Study:

  • To analyze age-specific bladder cancer incidence trends in Taiwan from 1997 to 2016.
  • To forecast future bladder cancer incidence rates up to 2025.
  • To evaluate the potential achievement of the WHO's 25% reduction goal for non-communicable diseases.

Main Methods:

  • Utilized an ensemble age-period-cohort model for trend estimation and forecasting.
  • Analyzed age-specific bladder cancer cases and population data for ages 25 and above.
  • Data spanned from 1997 to 2016 in Taiwan, with projections to 2025.

Main Results:

  • Bladder cancer incidence rates showed a consistent downward trend after 2003 for all ages and both sexes.
  • Projected age-standardized incidence rates for men in 2025 are 10.4 per 100,000, a 32.9% decrease from 2016.
  • Projected age-standardized incidence rates for women in 2025 are 3.7 per 100,000, a 33.9% decrease from 2016.

Conclusions:

  • Bladder cancer incidence in Taiwan is projected to continue its decreasing trend.
  • The study forecasts that Taiwan will achieve more than a 25% reduction in bladder cancer incidence from 2016 to 2025.
  • These findings support the feasibility of meeting global public health targets for non-communicable diseases.